STOCK TITAN

[D] Fusion Fuel Green PLC SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
D
Rhea-AI Filing Summary

Upexi (Nasdaq: UPXI) filed an 8-K disclosing two material events.

1) $500 million equity line. On 25-Jul-25 the company signed a Common Stock Purchase Agreement with A.G.P./Alliance Global Partners. Management may, at its sole discretion, sell the lesser of (i) $500 million or (ii) shares equal to 19.99 % of current outstanding stock, unless shareholder approval lifts the cap. Stock is issued at 95 % of VWAP via dollar or intraday orders. The facility ends after one year or when fully drawn. A companion Registration Rights Agreement requires a resale registration filing within 30 days and effectiveness within 60 days.

2) Additional Solana purchase. On 23-Jul-25 Upexi bought 83,000 SOL for $16.7 million ($201.34/SOL), lifting holdings to 1.9 million SOL valued above $381 million at the 22-Jul-25 spot price.

Implications: The equity line supplies flexible liquidity but could dilute shareholders by up to 20 % at a 5 % discount. The enlarged cryptocurrency position increases exposure to price volatility and concentration risk.

Upexi (Nasdaq: UPXI) ha presentato un modulo 8-K rivelando due eventi significativi.

1) Linea di capitale azionario da 500 milioni di dollari. Il 25 luglio 2025 la società ha firmato un Accordo per l'Acquisto di Azioni Ordinarie con A.G.P./Alliance Global Partners. La direzione può, a sua esclusiva discrezione, vendere il minore tra (i) 500 milioni di dollari o (ii) azioni pari al 19,99% delle azioni attualmente in circolazione, a meno che l'approvazione degli azionisti non rimuova questo limite. Le azioni sono emesse al 95% del prezzo medio ponderato per volume (VWAP) tramite ordini in dollari o intraday. La linea scade dopo un anno o al completo utilizzo. Un accordo parallelo sui Diritti di Registrazione richiede la presentazione della registrazione per la rivendita entro 30 giorni e l'efficacia entro 60 giorni.

2) Acquisto aggiuntivo di Solana. Il 23 luglio 2025 Upexi ha acquistato 83.000 SOL per 16,7 milioni di dollari (201,34 $/SOL), portando la detenzione a 1,9 milioni di SOL, valutati oltre 381 milioni di dollari al prezzo spot del 22 luglio 2025.

Implicazioni: La linea di capitale azionario fornisce liquidità flessibile ma potrebbe diluire gli azionisti fino al 20% con uno sconto del 5%. La posizione ampliata in criptovalute aumenta l'esposizione alla volatilità dei prezzi e al rischio di concentrazione.

Upexi (Nasdaq: UPXI) presentó un formulario 8-K revelando dos eventos materiales.

1) Línea de capital accionario de 500 millones de dólares. El 25 de julio de 2025 la compañía firmó un Acuerdo de Compra de Acciones Comunes con A.G.P./Alliance Global Partners. La dirección puede, a su sola discreción, vender el menor entre (i) 500 millones de dólares o (ii) acciones equivalentes al 19,99 % del capital social actual, a menos que la aprobación de los accionistas elimine este límite. Las acciones se emiten al 95 % del VWAP mediante órdenes en dólares o intradía. La línea finaliza después de un año o cuando se haya utilizado por completo. Un Acuerdo complementario de Derechos de Registro requiere la presentación de un registro para reventa en un plazo de 30 días y su efectividad dentro de 60 días.

2) Compra adicional de Solana. El 23 de julio de 2025 Upexi compró 83.000 SOL por 16,7 millones de dólares (201,34 $/SOL), elevando sus tenencias a 1,9 millones de SOL valorados en más de 381 millones de dólares al precio spot del 22 de julio de 2025.

Implicaciones: La línea de capital accionario proporciona liquidez flexible pero podría diluir a los accionistas hasta en un 20 % con un descuento del 5 %. La posición ampliada en criptomonedas aumenta la exposición a la volatilidad de precios y al riesgo de concentración.

Upexi (나스닥: UPXI)가 두 가지 중요 사건을 공시한 8-K 서류를 제출했습니다.

1) 5억 달러 규모의 주식 매입 라인. 2025년 7월 25일 회사는 A.G.P./Alliance Global Partners와 보통주 매입 계약을 체결했습니다. 경영진은 단독 재량으로 (i) 5억 달러 또는 (ii) 현재 발행 주식의 19.99%에 해당하는 주식 중 적은 금액을 주주 승인 없이 판매할 수 있습니다. 주식은 VWAP의 95% 가격으로 달러 또는 당일 주문을 통해 발행됩니다. 이 시설은 1년 후 또는 전액 사용 시 종료됩니다. 동반 등록 권리 계약은 30일 이내에 재판매 등록 신청을 요구하며 60일 이내에 효력이 발생해야 합니다.

2) 추가 솔라나 구매. 2025년 7월 23일 Upexi는 83,000 SOL을 1,670만 달러(주당 201.34달러)에 매입하여 보유량을 190만 SOL로 늘렸으며, 2025년 7월 22일 현물 가격 기준으로 3억 8,100만 달러 이상으로 평가됩니다.

의미: 이 주식 매입 라인은 유연한 유동성을 제공하지만 최대 20%까지 주주 희석이 발생할 수 있으며 5% 할인 가격으로 발행됩니다. 확대된 암호화폐 보유는 가격 변동성과 집중 위험 노출을 증가시킵니다.

Upexi (Nasdaq : UPXI) a déposé un formulaire 8-K dévoilant deux événements importants.

1) Ligne de capitaux propres de 500 millions de dollars. Le 25 juillet 2025, la société a signé un accord d'achat d'actions ordinaires avec A.G.P./Alliance Global Partners. La direction peut, à sa seule discrétion, vendre le moindre de (i) 500 millions de dollars ou (ii) des actions représentant 19,99 % des actions en circulation, sauf si l'approbation des actionnaires supprime ce plafond. Les actions sont émises à 95 % du VWAP via des ordres en dollars ou intrajournaliers. La facilité prend fin après un an ou lorsqu'elle est entièrement utilisée. Un accord de droits d'enregistrement associé exige un dépôt d'enregistrement pour la revente dans les 30 jours et son efficacité dans les 60 jours.

2) Achat supplémentaire de Solana. Le 23 juillet 2025, Upexi a acheté 83 000 SOL pour 16,7 millions de dollars (201,34 $/SOL), portant les avoirs à 1,9 million de SOL évalués à plus de 381 millions de dollars au prix spot du 22 juillet 2025.

Implications : La ligne de capitaux propres offre une liquidité flexible mais pourrait diluer les actionnaires jusqu'à 20 % avec une décote de 5 %. La position cryptomonnaie accrue augmente l'exposition à la volatilité des prix et au risque de concentration.

Upexi (Nasdaq: UPXI) hat ein 8-K eingereicht, das zwei wesentliche Ereignisse offenlegt.

1) 500-Millionen-Dollar-Aktienlinie. Am 25. Juli 2025 unterzeichnete das Unternehmen eine Vereinbarung zum Kauf von Stammaktien mit A.G.P./Alliance Global Partners. Das Management kann nach eigenem Ermessen den geringeren Betrag von (i) 500 Millionen Dollar oder (ii) Aktien im Wert von 19,99 % des aktuell ausstehenden Aktienkapitals verkaufen, sofern keine Aktionärszustimmung die Obergrenze aufhebt. Die Aktien werden zu 95 % des volumengewichteten Durchschnittspreises (VWAP) über Dollar- oder Intraday-Aufträge ausgegeben. Die Einrichtung endet nach einem Jahr oder wenn sie vollständig genutzt ist. Eine begleitende Registrierungsrechtsvereinbarung verlangt eine Wiederverkaufsregistrierung innerhalb von 30 Tagen und deren Wirksamkeit innerhalb von 60 Tagen.

2) Zusätzlicher Solana-Kauf. Am 23. Juli 2025 kaufte Upexi 83.000 SOL für 16,7 Millionen Dollar (201,34 $/SOL) und erhöhte damit den Bestand auf 1,9 Millionen SOL, bewertet mit über 381 Millionen Dollar zum Spotpreis vom 22. Juli 2025.

Auswirkungen: Die Aktienlinie bietet flexible Liquidität, könnte jedoch die Aktionäre um bis zu 20 % bei einem Abschlag von 5 % verwässern. Die erweiterte Kryptowährungsposition erhöht das Risiko von Preisvolatilität und Konzentration.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Equity line boosts liquidity but at potential 20% dilution; Solana buy diversifies assets yet heightens volatility—net impact balanced.

The $500 million commitment gives Upexi a sizeable, on-demand capital source without immediate leverage, enhancing funding optionality for working capital or acquisitions. Pricing at 95 % of VWAP is relatively shareholder-friendly versus PIPE norms. However, issuing nearly one-fifth of the float would weigh on EPS and voting power. The Solana accumulation, now >$381 million, provides mark-to-market upside but links enterprise value to crypto cycles, potentially increasing share-price beta. Overall, the filing is strategically useful but financially neutral until management signals how proceeds will be deployed.

TL;DR: Dilutive equity issuance and $381M crypto concentration materially raise capital structure and market risk; investors face pricing, regulatory and volatility uncertainties.

The equity facility’s 19.99 % cap skirts Nasdaq shareholder-approval thresholds but still represents material dilution, especially given the 5 % discount. Should the share price weaken, additional issuance could create a downward spiral. Compliance lapses on the registration timetable would suspend access to funds when most needed. The enlarged Solana exposure concentrates >$381 million of corporate assets in a single, highly volatile token, introducing mark-to-market earnings noise, liquidity risk, and potential regulatory scrutiny. Collectively, these moves tilt the risk-reward profile to the downside.

Upexi (Nasdaq: UPXI) ha presentato un modulo 8-K rivelando due eventi significativi.

1) Linea di capitale azionario da 500 milioni di dollari. Il 25 luglio 2025 la società ha firmato un Accordo per l'Acquisto di Azioni Ordinarie con A.G.P./Alliance Global Partners. La direzione può, a sua esclusiva discrezione, vendere il minore tra (i) 500 milioni di dollari o (ii) azioni pari al 19,99% delle azioni attualmente in circolazione, a meno che l'approvazione degli azionisti non rimuova questo limite. Le azioni sono emesse al 95% del prezzo medio ponderato per volume (VWAP) tramite ordini in dollari o intraday. La linea scade dopo un anno o al completo utilizzo. Un accordo parallelo sui Diritti di Registrazione richiede la presentazione della registrazione per la rivendita entro 30 giorni e l'efficacia entro 60 giorni.

2) Acquisto aggiuntivo di Solana. Il 23 luglio 2025 Upexi ha acquistato 83.000 SOL per 16,7 milioni di dollari (201,34 $/SOL), portando la detenzione a 1,9 milioni di SOL, valutati oltre 381 milioni di dollari al prezzo spot del 22 luglio 2025.

Implicazioni: La linea di capitale azionario fornisce liquidità flessibile ma potrebbe diluire gli azionisti fino al 20% con uno sconto del 5%. La posizione ampliata in criptovalute aumenta l'esposizione alla volatilità dei prezzi e al rischio di concentrazione.

Upexi (Nasdaq: UPXI) presentó un formulario 8-K revelando dos eventos materiales.

1) Línea de capital accionario de 500 millones de dólares. El 25 de julio de 2025 la compañía firmó un Acuerdo de Compra de Acciones Comunes con A.G.P./Alliance Global Partners. La dirección puede, a su sola discreción, vender el menor entre (i) 500 millones de dólares o (ii) acciones equivalentes al 19,99 % del capital social actual, a menos que la aprobación de los accionistas elimine este límite. Las acciones se emiten al 95 % del VWAP mediante órdenes en dólares o intradía. La línea finaliza después de un año o cuando se haya utilizado por completo. Un Acuerdo complementario de Derechos de Registro requiere la presentación de un registro para reventa en un plazo de 30 días y su efectividad dentro de 60 días.

2) Compra adicional de Solana. El 23 de julio de 2025 Upexi compró 83.000 SOL por 16,7 millones de dólares (201,34 $/SOL), elevando sus tenencias a 1,9 millones de SOL valorados en más de 381 millones de dólares al precio spot del 22 de julio de 2025.

Implicaciones: La línea de capital accionario proporciona liquidez flexible pero podría diluir a los accionistas hasta en un 20 % con un descuento del 5 %. La posición ampliada en criptomonedas aumenta la exposición a la volatilidad de precios y al riesgo de concentración.

Upexi (나스닥: UPXI)가 두 가지 중요 사건을 공시한 8-K 서류를 제출했습니다.

1) 5억 달러 규모의 주식 매입 라인. 2025년 7월 25일 회사는 A.G.P./Alliance Global Partners와 보통주 매입 계약을 체결했습니다. 경영진은 단독 재량으로 (i) 5억 달러 또는 (ii) 현재 발행 주식의 19.99%에 해당하는 주식 중 적은 금액을 주주 승인 없이 판매할 수 있습니다. 주식은 VWAP의 95% 가격으로 달러 또는 당일 주문을 통해 발행됩니다. 이 시설은 1년 후 또는 전액 사용 시 종료됩니다. 동반 등록 권리 계약은 30일 이내에 재판매 등록 신청을 요구하며 60일 이내에 효력이 발생해야 합니다.

2) 추가 솔라나 구매. 2025년 7월 23일 Upexi는 83,000 SOL을 1,670만 달러(주당 201.34달러)에 매입하여 보유량을 190만 SOL로 늘렸으며, 2025년 7월 22일 현물 가격 기준으로 3억 8,100만 달러 이상으로 평가됩니다.

의미: 이 주식 매입 라인은 유연한 유동성을 제공하지만 최대 20%까지 주주 희석이 발생할 수 있으며 5% 할인 가격으로 발행됩니다. 확대된 암호화폐 보유는 가격 변동성과 집중 위험 노출을 증가시킵니다.

Upexi (Nasdaq : UPXI) a déposé un formulaire 8-K dévoilant deux événements importants.

1) Ligne de capitaux propres de 500 millions de dollars. Le 25 juillet 2025, la société a signé un accord d'achat d'actions ordinaires avec A.G.P./Alliance Global Partners. La direction peut, à sa seule discrétion, vendre le moindre de (i) 500 millions de dollars ou (ii) des actions représentant 19,99 % des actions en circulation, sauf si l'approbation des actionnaires supprime ce plafond. Les actions sont émises à 95 % du VWAP via des ordres en dollars ou intrajournaliers. La facilité prend fin après un an ou lorsqu'elle est entièrement utilisée. Un accord de droits d'enregistrement associé exige un dépôt d'enregistrement pour la revente dans les 30 jours et son efficacité dans les 60 jours.

2) Achat supplémentaire de Solana. Le 23 juillet 2025, Upexi a acheté 83 000 SOL pour 16,7 millions de dollars (201,34 $/SOL), portant les avoirs à 1,9 million de SOL évalués à plus de 381 millions de dollars au prix spot du 22 juillet 2025.

Implications : La ligne de capitaux propres offre une liquidité flexible mais pourrait diluer les actionnaires jusqu'à 20 % avec une décote de 5 %. La position cryptomonnaie accrue augmente l'exposition à la volatilité des prix et au risque de concentration.

Upexi (Nasdaq: UPXI) hat ein 8-K eingereicht, das zwei wesentliche Ereignisse offenlegt.

1) 500-Millionen-Dollar-Aktienlinie. Am 25. Juli 2025 unterzeichnete das Unternehmen eine Vereinbarung zum Kauf von Stammaktien mit A.G.P./Alliance Global Partners. Das Management kann nach eigenem Ermessen den geringeren Betrag von (i) 500 Millionen Dollar oder (ii) Aktien im Wert von 19,99 % des aktuell ausstehenden Aktienkapitals verkaufen, sofern keine Aktionärszustimmung die Obergrenze aufhebt. Die Aktien werden zu 95 % des volumengewichteten Durchschnittspreises (VWAP) über Dollar- oder Intraday-Aufträge ausgegeben. Die Einrichtung endet nach einem Jahr oder wenn sie vollständig genutzt ist. Eine begleitende Registrierungsrechtsvereinbarung verlangt eine Wiederverkaufsregistrierung innerhalb von 30 Tagen und deren Wirksamkeit innerhalb von 60 Tagen.

2) Zusätzlicher Solana-Kauf. Am 23. Juli 2025 kaufte Upexi 83.000 SOL für 16,7 Millionen Dollar (201,34 $/SOL) und erhöhte damit den Bestand auf 1,9 Millionen SOL, bewertet mit über 381 Millionen Dollar zum Spotpreis vom 22. Juli 2025.

Auswirkungen: Die Aktienlinie bietet flexible Liquidität, könnte jedoch die Aktionäre um bis zu 20 % bei einem Abschlag von 5 % verwässern. Die erweiterte Kryptowährungsposition erhöht das Risiko von Preisvolatilität und Konzentration.

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM D

Notice of Exempt Offering of Securities

OMB APPROVAL
OMB Number: 3235-0076
Estimated average burden
hours per response: 4.00

1. Issuer's Identity

CIK (Filer ID Number) Previous Names
None
Entity Type
0001819794
Fusion Fuel Green Ltd
X Corporation
Limited Partnership
Limited Liability Company
General Partnership
Business Trust
Other (Specify)

Name of Issuer
Fusion Fuel Green PLC
Jurisdiction of Incorporation/Organization
IRELAND
Year of Incorporation/Organization
Over Five Years Ago
X Within Last Five Years (Specify Year) 2020
Yet to Be Formed

2. Principal Place of Business and Contact Information

Name of Issuer
Fusion Fuel Green PLC
Street Address 1 Street Address 2
10 EARLSFORT TERRACE DUBLIN 2
City State/Province/Country ZIP/PostalCode Phone Number of Issuer
DUBLIN IRELAND D02 T380 +351 960 439 641

3. Related Persons

Last Name First Name Middle Name
Figueira de Chaves Frederico
Street Address 1 Street Address 2
9 Pembroke Street Upper
City State/Province/Country ZIP/PostalCode
Dublin IRELAND D02 KR83
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Jones Gavin
Street Address 1 Street Address 2
9 Pembroke Street Upper
City State/Province/Country ZIP/PostalCode
Dublin IRELAND D02 KR83
Relationship: X Executive Officer Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Schwartz Jeffrey
Street Address 1 Street Address 2
9 Pembroke Street Upper
City State/Province/Country ZIP/PostalCode
Dublin IRELAND D02 KR83
Relationship: X Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Lundetrae Rune Magnus
Street Address 1 Street Address 2
9 Pembroke Street Upper
City State/Province/Country ZIP/PostalCode
Dublin IRELAND D02 KR83
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Backwell John-Paul
Street Address 1 Street Address 2
9 Pembroke Street Upper
City State/Province/Country ZIP/PostalCode
Dublin IRELAND D02 KR83
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Ingargiola Luisa
Street Address 1 Street Address 2
9 Pembroke Street Upper
City State/Province/Country ZIP/PostalCode
Dublin IRELAND D02 KR83
Relationship: Executive Officer X Director Promoter

Clarification of Response (if Necessary):


4. Industry Group

Agriculture
Banking & Financial Services
Commercial Banking
Insurance
Investing
Investment Banking
Pooled Investment Fund
Is the issuer registered as
an investment company under
the Investment Company
Act of 1940?
Yes No
Other Banking & Financial Services
Business Services
Energy
Coal Mining
Electric Utilities
Energy Conservation
Environmental Services
Oil & Gas
X Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
Construction
REITS & Finance
Residential
Other Real Estate
Retailing
Restaurants
Technology
Computers
Telecommunications
Other Technology
Travel
Airlines & Airports
Lodging & Conventions
Tourism & Travel Services
Other Travel
Other

5. Issuer Size

Revenue Range OR Aggregate Net Asset Value Range
No Revenues No Aggregate Net Asset Value
$1 - $1,000,000 $1 - $5,000,000
$1,000,001 - $5,000,000 $5,000,001 - $25,000,000
$5,000,001 - $25,000,000 $25,000,001 - $50,000,000
$25,000,001 - $100,000,000 $50,000,001 - $100,000,000
Over $100,000,000 Over $100,000,000
X Decline to Disclose Decline to Disclose
Not Applicable Not Applicable

6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

Rule 504(b)(1) (not (i), (ii) or (iii))
Rule 504 (b)(1)(i)
Rule 504 (b)(1)(ii)
Rule 504 (b)(1)(iii)
X Rule 506(b)
Rule 506(c)
Securities Act Section 4(a)(5)
Investment Company Act Section 3(c)
Section 3(c)(1) Section 3(c)(9)
Section 3(c)(2) Section 3(c)(10)
Section 3(c)(3) Section 3(c)(11)
Section 3(c)(4) Section 3(c)(12)
Section 3(c)(5) Section 3(c)(13)
Section 3(c)(6) Section 3(c)(14)
Section 3(c)(7)

7. Type of Filing

X New Notice Date of First Sale 2025-02-28 First Sale Yet to Occur
Amendment

8. Duration of Offering

Does the Issuer intend this offering to last more than one year?
Yes X No

9. Type(s) of Securities Offered (select all that apply)

X Equity Pooled Investment Fund Interests
Debt Tenant-in-Common Securities
X Option, Warrant or Other Right to Acquire Another Security Mineral Property Securities
X Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security Other (describe)

10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
Yes X No

Clarification of Response (if Necessary):

11. Minimum Investment

Minimum investment accepted from any outside investor $0 USD

12. Sales Compensation

Recipient
Recipient CRD Number X None
(Associated) Broker or Dealer X None
(Associated) Broker or Dealer CRD Number X None
Street Address 1 Street Address 2
City State/Province/Country ZIP/Postal Code
State(s) of Solicitation (select all that apply)
Check "All States" or check individual States
All States
Foreign/non-US

13. Offering and Sales Amounts

Total Offering Amount $1,300,000 USD
or Indefinite
Total Amount Sold $1,300,000 USD
Total Remaining to be Sold $0 USD
or Indefinite

Clarification of Response (if Necessary):

14. Investors

Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
3

15. Sales Commissions & Finder's Fees Expenses

Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

Sales Commissions $0 USD
Estimate
Finders' Fees $0 USD
Estimate

Clarification of Response (if Necessary):

16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

$0 USD
Estimate

Clarification of Response (if Necessary):

Signature and Submission

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

Terms of Submission

In submitting this notice, each issuer named above is:
  • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
  • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of: (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
  • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

Issuer Signature Name of Signer Title Date
Fusion Fuel Green PLC John-Paul Backwell John-Paul Backwell CEO 2025-07-25

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

* This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


FAQ

How large is Upexi's new equity facility with A.G.P./Alliance Global Partners?

The Common Stock Purchase Agreement allows Upexi to sell up to $500 million in common stock, subject to a 19.99 % share cap.

What pricing formula will be used for future UPXI share sales?

Shares will be issued at 95 % of the volume-weighted average price (VWAP) for the specified order period.

When must Upexi file the resale registration statement?

Under the Registration Rights Agreement, the company must file within 30 days and achieve SEC effectiveness within 60 days.

How many Solana tokens does Upexi now hold?

After purchasing 83,000 SOL, Upexi holds 1.9 million SOL valued at over $381 million (spot price $200.60).

What is the potential shareholder dilution from the equity line?

Absent additional approval, dilution is capped at 19.99 % of existing outstanding shares.
Fusion Fuel Green Plc

NASDAQ:HTOO

HTOO Rankings

HTOO Latest News

HTOO Latest SEC Filings

HTOO Stock Data

5.28M
704.63k
27.19%
4.86%
0.59%
Utilities - Renewable
Utilities
Link
Ireland
Dublin